Clinical Trials Directory

Trials / Completed

CompletedNCT05836181

The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.

The Effect of Eye Movement Desensitization and Reprocessing Reducing Anxiety, Depressive Symptoms, Blood Pressure, and Heart Rate Variability in Primary Hypertension: A Randomized Controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Miao-Yi Chen · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Eye Movement Desensitization and Reprocessing intervention may improve anxiety, depression, systolic blood pressure and heart rate variability in patients with hypertension.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEye Movement Desensitization and ReprocessingEffects of Eye Movement Desensitization and Reprocessing on Anxiety, Depression, Quality of Life, Blood Pressure and Heart Rate Variability in Patients with Hypertension.

Timeline

Start date
2014-02-01
Primary completion
2016-12-10
Completion
2016-12-28
First posted
2023-05-01
Last updated
2023-05-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05836181. Inclusion in this directory is not an endorsement.